Quarterly Schedule of Portfolio Holdings of Registered
|
Management Investment Company
|
Investment Company Act file number: 811-05807
|
Eagle Capital Growth Fund, Inc.
|
(Exact name of registrant as specified in charter)
|
225 East Mason Street, Suite 802, Milwaukee, WI 53202-3657
|
(Address of principal executive offices) (zip code)
|
Luke E. Sims, President
|
Eagle Capital Growth Fund, Inc.
|
225 East Mason Street
|
Suite 802
|
Milwaukee, WI 53202-3657
|
(414) 765-1107
|
(Name and address of agent for service)
|
Registrant's telephone number, including area code:
|
ITEM 1.
|
SCHEDULE OF INVESTMENTS
|
Common Stock (70.8% of total investments)
|
LEVEL ONE
|
|||||||||||||||
Industry
|
||||||||||||||||
Consumer
|
Shares
|
Cost
|
Market Value
|
% Total Inv.
|
||||||||||||
Colgate-Palmolive Co.
|
6,000 | $ | 72,938 | $ | 643,320 | |||||||||||
PepsiCo, Inc.
|
10,000 | 168,296 | 707,700 | |||||||||||||
Procter & Gamble Co.
|
11,000 | 658,137 | 762,960 | |||||||||||||
$ | 2,113,980 | (8.6 | %) | |||||||||||||
Data Processing
|
||||||||||||||||
Automatic Data Processing, Inc.
|
24,000 | 877,946 | 1,407,840 | |||||||||||||
Paychex, Inc.
|
31,000 | 797,952 | 1,031,990 | |||||||||||||
$ | 2,439,830 | (10.0 | %) | |||||||||||||
Drug/Medical Device
|
||||||||||||||||
Abbott Laboratories Inc.
|
7,500 | 365,998 | 514,200 | |||||||||||||
Johnson & Johnson
|
12,500 | 484,536 | 861,375 | |||||||||||||
Stryker Corp.
|
20,000 | 95,500 | 1,113,200 | |||||||||||||
$ | 2,488,775 | (10.2 | %) | |||||||||||||
Industrial
|
||||||||||||||||
Emerson Electric Co.
|
22,000 | 990,207 | 1,061,940 | |||||||||||||
Hillenbrand, Inc.
|
57,000 | 1,109,325 | 1,036,830 | |||||||||||||
Illinois Tool Works Inc.
|
17,000 | 786,916 | 1,010,990 | |||||||||||||
Sigma-Aldrich Corp.
|
16,000 | 498,184 | 1,151,550 | |||||||||||||
Waters Corp.*
|
6,000 | 302,341 | 499,980 | |||||||||||||
$ | 4,761,290 | (19.5 | %) | |||||||||||||
Mutual Fund Managers
|
||||||||||||||||
Eaton Vance Corp.
|
34,000 | 801,121 | 984,640 | |||||||||||||
Franklin Resources, Inc.
|
4,500 | 427,398 | 562,815 | |||||||||||||
$ | 1,547,455 | (6.3 | %) | |||||||||||||
Insurance
|
||||||||||||||||
Berkshire Hathaway Inc.*
|
17,000 | 1,303,475 | 1,499,400 | |||||||||||||
The Chubb Corporation
|
14,000 | 715,049 | 1,067,920 | |||||||||||||
$ | 2,567,320 | (10.5 | %) | |||||||||||||
Retail/Distribution
|
||||||||||||||||
Sysco Corp.
|
20,000 | 142,750 | 625,400 | |||||||||||||
$ | 625,400 | (2.6 | %) | |||||||||||||
Closed-End Funds
|
||||||||||||||||
Diamond Hill Financial Trends Fund, Inc.
|
69,219 | 676,480 | 779,406 | |||||||||||||
$ | 779,406 | (3.2 | %) | |||||||||||||
Total common stock investments
|
$ | 17,323,456 | ||||||||||||||
Money Market Funds (29.2% of total investments)
|
LEVEL ONE
|
|||||||||||||||
Federated Government Obligations Fund #5 Institutional, .02%**
|
7,146,762 | 7,146,762 | 7,146,762 | (29.2 | %) | |||||||||||
Total investments
|
$ | 24,470,218 | ||||||||||||||
All other assets less liabilities
|
31,775 | |||||||||||||||
Accrued investment advisory fees
|
14,637 | |||||||||||||||
Total net assets
|
$ | 24,487,357 |
*
|
Non-dividend paying security
|
**
|
The rate shown represents the 7-day yield at September 30, 2012.
|
Gross unrealized appreciation
|
$
|
6,141,278
|
||
Gross unrealized depreciation
|
( 92,371
|
)
|
||
Net unrealized appreciation
|
$
|
6,048,907
|
||
Federal income tax basis
|
$
|
11,274,550
|
ITEM 2.
|
Controls and Procedures
|
|
(a)
|
As of October 1, 2012, an evaluation of the effectiveness of the registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) was performed by management with the participation of the registrant's President and Chief Executive Officer (who is the principal executive officer of the registrant) and the registrant’s Chief Financial Officer (who is the principal financial officer of the registrant). Based on that evaluation, the registrant's President and Chief Executive Officer and Chief Financial Officer concluded that the registrant's disclosure controls and procedures are effectively designed to ensure that information required to be disclosed by the registrant is recorded, processed, summarized and reported within the time periods specified by the Commission's rules and forms, and that information required to be disclosed by the registrant has been accumulated and communicated to the registrant's management, including its principal executive officer and principal financial officer, or persons performing similar functions as appropriate to allow timely decisions regarding required disclosure.
|
|
(b)
|
Fair Value Accounting—Accounting standards require certain assets and liabilities be reported at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the inputs and valuation techniques used to measure fair value.
|